Sustaining Member

Actelion Pharmaceuticals

Organization Address
South San Francisco, CA

Organization Phone
(650) 808-6536


Organization Description

Actelion Ltd is a biopharmaceutical company, with its corporate headquarters in Allschwil/Basel, Switzerland. Actelion’s first drug Tracleer™, an orally available dual endothelin receptor antagonist, has been approved as a therapy for pulmonary arterial hypertension. Actelion markets Tracleer™ through its own subsidiaries in key markets worldwide, including the United States (based in South San Francisco), the European Union as well as Canada and Switzerland.